Table 3.

Technical characteristics including antiplatelet therapy, and clinical and angiographic follow-up at 6 months.

Patient No.	Anti-platelet protocol	Device and associated intracranial technique	TICI	Postoperative hemorrhage	Stent used	mRS at 3 months	Follow-up arteriogram at 6 months Stent patency	Follow-up arteriogram at 6 months Stent displacement
1	1 g of LAS IV + 300 mg Clopidogrel PO	SOLITAIRE	2B	NO	Wingspan 4.5   × 20 mm Wingspan 4.5 × 20 mm	0	YES	YES
2	1 g of LAS IV + Abciximab	SOLITAIRE	3	NO	Wingspan 4.5 × 20 mm	0	YES	NO
3	1 g of LAS IV	-	3	NO	Wingspan 4.5 × 20 mm Wingspan 4 × 20 mm Wallstent 5 × 30 mm	3	YES	YES
4	1 g of LAS IV + 300 mg Clopidogrel PO	SOLITAIRE	3	NO	Wingspan 4.5 × 25 mm Wingspan 4 × 20 mm Wallstent 5 × 30 Wallstent 7 × 30	0	YES	YES
5	1 g of LAS IV + Tirofiban	SOLITAIRE	3	NO	Wingspan 4.5 × 20 mm Wingspan 4.5 × 15 mm	2	YES	NO
6	1 g of LAS IV + 300 mg Clopidogrel PO	SOLITAIRE	2B	NO	Wingspan 4.5 × 25 mm Wingspan 4.5 × 20 mm	1	YES	NO
7	1 g of LAS IV + 300 mg Clopidogrel PO	-	3	NO	Wingspan 4.5 × 25 mm Wallstent 5 × 30 mm	1	YES	YES
8	1 g of LAS IV + Tirofiban	SOLITAIRE	3	NO	Wingspan 4.5 × 25 mm Wingspan 4.5 × 25 mm	1	YES	NO
9	1 g of LAS IV + Tirofiban	-	3	NO	Wingspan 4.5 × 25 mm	0	YES	NO
10	1 g of LAS IV + Tirofiban	-	3	NO	Wingspan 4.5 × 20 mm Wingspan 4.5 × 15 mm Wallstent 5 × 30 mm	0	YES	YES
11	1 g of LAS IV	SOLITAIRE	2B	NO	Wingspan 4.5 × 20 mm	0	YES	NO

IV: intravenous; LAS: lysine acetylsalicylate; mos: months; mRS: modified Rankin Scale; PO: by mouth